Tag: drugdevelopment

Renaissance Pharma secures FDA Fast Track Designation and IND clearance for Daretabart in high-risk neuroblastoma

Oragenics doses first patient in phase 2a clinical trial of drug for mild traumatic brain injury

Bracco invests in GMP manufacturing facility for cell therapy products

Virica Biotech and Fujifilm Biosciences collaborate to develop production enhancers

FDA approves new high dose regimen of Spinraza (nusinersen) for spinal muscular atrophy

Apotex receives first US FDA tentative approval for a generic version of Ozempic (semaglutide injection)

Lynk Pharmaceuticals announces NDA acceptance for zemprocitinib

Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

$149 a month new oral GLP-1 pill for weight loss (Foundayo (orforglipron)) now available in the US

European Commission approves Kygevvi (doxecitine and doxribtimine) as first and only treatment for thymidine kinase 2 deficiency